Back in the good ole days, when the share price was double digit, the company had a US based management team and over half of the board was US based with national healthcare or insurance experience. Tremendous connectivity and time spent in the market. I am not positive, but I believe we are trying to sell into the US with a leadership team that sits half way around the world. Could be wrong, I do not know. Maybe the old lot was not given the time following guideline inclusion to ramp up the company.
Add to My Watchlist
What is My Watchlist?
